11. International Symposium of Gastroenterology
Datum
12. 5. 2016 - 14. 5. 2016Místo
Rusko, Petrohrad
Země
AUT, BIH, CAN, CZE, DNK, EST, DEU, ITA, KAZ, MNG, POL, SVK, SRB, RUS, ESP, UKR, GBR
Počet účastníků
374
Témata
NAFLD and metabolic syndrome; Progress in therapeutic endoscopy; Inflammatory Bowel Disease; Diagnostic and therapeutic approaches in GERD; Hepatology; Colorectal malignancy
Akreditace
11. mezinárodní sympozium gastroenterologie (ISG) je akreditováno Evropskou akreditační radou pro dalšího vzdělávání ve zdravotnictví (EACCME) a poskytuje kontinuální vzdělávací programy CME pro zdravotnické odborníky. EACCME je instituce Evropské unie lékařských specialistů (UEMS).
11. mezinárodní sympozium gastroenterologie (ISG) je limitováno pro maximálně (nebo „ne více než“) 9 hodin evropských kreditů CME. Každý zdravotnický odborník si může nárokovat pouze hodiny kreditů skutečně strávené edukací.
Program
Abstrakta
Opening session
Metabolic syndrome – Obesity as a risk factor for GI-disease development
Session I: NAFLD and comorbidity
Current approaches to diagnosis and treatment of NAFLD
NAFLD and alcoholic liver disease: Similarities and differences
Session II: Progress in therapeutic endoscopy
Endoscopic surgery – Emerging techniques which completely changed the current clinical practice
The European perspective of endoscopic submucosal dissection
Endoscopic diagnosis and tissue sampling in Barrett’s oesophagus
Is POEM a valid method for the treatment of achalasia patients?
Session III: Inflammatory bowel disease
Progress in conservative therapy in IBD
Can we use the aminosalicylates in clinical practice in IBD patients?
Laparoscopic procedures in IBD: Limits and advantages
Endoscopic surveillance of colorectal carcinoma and dysplasia in IBD patients
Functional GI disorders and IBD debut (clinical cases)
Session IV: Diagnostic and therapeutic approaches in GERD
Questions of diagnostics and treatment of different forms of GERD
GERD complications: Barrett’s metaplasia and others. Recommendation for clinical practice
GERD in patients with metabolic syndrome
Session V: Hepatology
Diagnostic and therapeutic possibilities in primary sclerosing cholangitis
Alcoholic liver diseases: Diagnostic and therapeutic possibilities
Session VI: Colorectal malignancy
Screening of colorectal carcinoma: Hot topics in current clinical gastroenterology
IBD as a risk factor for colorectal carcinoma. A real threat or more likely fiction at this time?
How to make the screening for colorectal carcinoma more effective
Fotogalerie ISG 2016
